Capillary fragility and doxium. A controlled clinical trial.
D002198:Capillary Fragility / Q000187:drug effects*; D002199:Capillary Permeability / Q000187:drug effects; D002200:Capillary Resistance / Q000187:drug effects; D003920:Diabetes Mellitus / Q000188:drug therapy; D006490:Hemostatics / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology* / Q000627:therapeutic use; D012867:Skin / Q000098:blood supply; D013451:Sulfonic Acids / Q000494:pharmacology / Q000627:therapeutic use
D006490:Hemostatics; D000644:Quaternary Ammonium Compounds; D013451:Sulfonic Acids